167 related articles for article (PubMed ID: 33462533)
1. 8-cyanobenzothiazinone analogs with potent antitubercular activity.
Zhang G; Sheng L; Hegde P; Li Y; Aldrich CC
Med Chem Res; 2021; 30(2):449-458. PubMed ID: 33462533
[TBL] [Abstract][Full Text] [Related]
2. The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis.
Makarov V; Neres J; Hartkoorn RC; Ryabova OB; Kazakova E; Šarkan M; Huszár S; Piton J; Kolly GS; Vocat A; Conroy TM; Mikušová K; Cole ST
Antimicrob Agents Chemother; 2015 Aug; 59(8):4446-52. PubMed ID: 25987616
[TBL] [Abstract][Full Text] [Related]
3. Spirocyclic and Bicyclic 8-Nitrobenzothiazinones for Tuberculosis with Improved Physicochemical and Pharmacokinetic Properties.
Zhang G; Howe M; Aldrich CC
ACS Med Chem Lett; 2019 Mar; 10(3):348-351. PubMed ID: 30891138
[TBL] [Abstract][Full Text] [Related]
4. Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1.
Richter A; Rudolph I; Möllmann U; Voigt K; Chung CW; Singh OMP; Rees M; Mendoza-Losana A; Bates R; Ballell L; Batt S; Veerapen N; Fütterer K; Besra G; Imming P; Argyrou A
Sci Rep; 2018 Sep; 8(1):13473. PubMed ID: 30194385
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, structures, reactivity and medicinal chemistry of antitubercular benzothiazinones.
Seidel RW; Richter A; Goddard R; Imming P
Chem Commun (Camb); 2023 Apr; 59(32):4697-4715. PubMed ID: 36974371
[TBL] [Abstract][Full Text] [Related]
6. Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1.
Trefzer C; Škovierová H; Buroni S; Bobovská A; Nenci S; Molteni E; Pojer F; Pasca MR; Makarov V; Cole ST; Riccardi G; Mikušová K; Johnsson K
J Am Chem Soc; 2012 Jan; 134(2):912-5. PubMed ID: 22188377
[TBL] [Abstract][Full Text] [Related]
7. [Effect of physicochemical properties on the pharmacokinetic parameters of the new representative of benzothiazinones antituberculosis drug macozinonе].
Khokhlov AL; Mariandyshev AO; Shcherbakova VS; Ozerova IV; Kazaishvili YG; Igumnova OV; Bolgarina AA; Rudoy BA
Ter Arkh; 2020 Dec; 92(12):165-171. PubMed ID: 33720590
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents.
Liu L; Kong C; Fumagalli M; Savková K; Xu Y; Huszár S; Sammartino JC; Fan D; Chiarelli LR; Mikušová K; Sun Z; Qiao C
Eur J Med Chem; 2020 Dec; 208():112773. PubMed ID: 32898793
[TBL] [Abstract][Full Text] [Related]
9. Easily accessed nitroquinolones exhibiting potent and selective anti-tubercular activity.
Dube PS; Legoabe LJ; Jordaan A; Jesumoroti OJ; Tshiwawa T; Warner DF; Beteck RM
Eur J Med Chem; 2021 Mar; 213():113207. PubMed ID: 33524688
[TBL] [Abstract][Full Text] [Related]
10. Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents.
Fan D; Wang B; Stelitano G; Savková K; Shi R; Huszár S; Han Q; Mikušová K; Chiarelli LR; Lu Y; Qiao C
J Med Chem; 2021 Oct; 64(19):14526-14539. PubMed ID: 34609861
[TBL] [Abstract][Full Text] [Related]
11. Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-β-D-ribose 2'-epimerase DprE1 of Mycobacterium tuberculosis.
Trefzer C; Rengifo-Gonzalez M; Hinner MJ; Schneider P; Makarov V; Cole ST; Johnsson K
J Am Chem Soc; 2010 Oct; 132(39):13663-5. PubMed ID: 20828197
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones.
Madikizela B; Eckhardt T; Goddard R; Richter A; Lins A; Lehmann C; Imming P; Seidel RW
Med Chem Res; 2021; 30(8):1523-1533. PubMed ID: 34131377
[TBL] [Abstract][Full Text] [Related]
13. Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.
Foo CS; Lechartier B; Kolly GS; Boy-Röttger S; Neres J; Rybniker J; Lupien A; Sala C; Piton J; Cole ST
Antimicrob Agents Chemother; 2016 Nov; 60(11):6451-6459. PubMed ID: 27527085
[TBL] [Abstract][Full Text] [Related]
14. Nitroarenes as Antitubercular Agents: Stereoelectronic Modulation to Mitigate Mutagenicity.
Landge S; Ramachandran V; Kumar A; Neres J; Murugan K; Sadler C; Fellows MD; Humnabadkar V; Vachaspati P; Raichurkar A; Sharma S; Ravishankar S; Guptha S; Sambandamurthy VK; Balganesh TS; Ugarkar BG; Balasubramanian V; Bandodkar BS; Panda M
ChemMedChem; 2016 Feb; 11(3):331-9. PubMed ID: 26751718
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis.
Piton J; Vocat A; Lupien A; Foo CS; Riabova O; Makarov V; Cole ST
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012754
[TBL] [Abstract][Full Text] [Related]
16. Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents.
Shi R; Wang B; Stelitano G; Wu X; Shan Y; Wu Y; Wang X; Chiarelli LR; Lu Y; Qiao C
ACS Med Chem Lett; 2022 Apr; 13(4):593-598. PubMed ID: 35450361
[TBL] [Abstract][Full Text] [Related]
17. [The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169)].
Mariandyshev AO; Khokhlov AL; Smerdin SV; Shcherbakova VS; Igumnova OV; Ozerova IV; Bolgarina AA; Nikitina NA
Ter Arkh; 2020 Apr; 92(3):61-72. PubMed ID: 32598795
[TBL] [Abstract][Full Text] [Related]
18. Deuteration of BTZ043 Extends the Lifetime of Meisenheimer Intermediates to the Antituberculosis Nitroso Oxidation State.
Liu R; Krchnak V; Brown SN; Miller MJ
ACS Med Chem Lett; 2019 Oct; 10(10):1462-1466. PubMed ID: 31620234
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors.
Batt SM; Jabeen T; Bhowruth V; Quill L; Lund PA; Eggeling L; Alderwick LJ; Fütterer K; Besra GS
Proc Natl Acad Sci U S A; 2012 Jul; 109(28):11354-9. PubMed ID: 22733761
[TBL] [Abstract][Full Text] [Related]
20. Identification of benzothiazones containing a hexahydropyrrolo[3,4-
Ma X; Han B; Wang A; Yang L; Huang M; Chowdhury K; Gu J; Zhang K; Lv K
RSC Adv; 2020 Apr; 10(24):14410-14414. PubMed ID: 35498504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
